Shareholders Revolt Over AstraZeneca Executive Pay
May 29, 2018
Shareholders vote against or abstain from vote over pay package for pharmaceutical company CEO.
At the recent AstraZeneca annual shareholder meeting, more than 37% of shareholders voted against or abstained from the vote over a £9.4m pay package for chief executive Pascal Soriot, according to an article from The Guardian. This is reportedly the second such rebuke in the past two years, even though it was a drop from £14.3m a year earlier.
AstraZeneca reported a 46% drop in operating profits for the first quarter, according to The Guardian, with earnings falling to $896m, attributed to increased costs and generic drug competitors to the company’s Crestor cholesterol medicine. Shareholders were reportedly opposed to what some cited as “overpayment for underperformance.”
Many facilities handle dangerous processes and products on a daily basis. Keeping everything under control demands well-trained people working with the best equipment.
Enhance the training experience and increase retention by training hands-on in Emerson's Interactive Plant Environment. Build skills here so you have them where and when it matters...
See how Rosemount™ 625IR Fixed Gas Detector helps keep workers safe with ultra-fast response times to detect hydrocarbon gases before they can create dangerous situations.
